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Pneumatocele-Induced Pneumothorax in a Patient with Post-
COVID-19 Pneumonitis. A Case Report 
Kevin O. Wortman II,1 Kevin O. Wortman Sr.2 
Abstract 
Background: The COVID-19 pandemic has been challenging medical professionals and facilities for over a year now. Much of the literature describes 
pathologic lung changes and complications associated with SARS-CoV-2, with pneumothorax and pneumatoceles not being uncommon. The Case: We 
describe a case involving a patient that presented to the emergency department with a pneumothorax. Three weeks prior, the patient was hospitalized 
for 10 days in acute respiratory distress secondary to SARS-CoV-2 pneumonia, which did not require ventilator support. Follow up imaging revealed a 7 cm 
(AP) x 4.6 cm (transverse) x 2.5 (cc) cm pneumatocele. Conclusion: We speculate that antecedent rupture of an unrecognized pneumatocele likely caused 
lung collapse leading to the patient’s pneumothorax. This review delves into the etiology of both pneumothoraxes and pneumatoceles along with their 
relation to SARS-CoV-2 pneumonia. 
 




This article describes the clinical course of a patient that presented to 
an Emergency Department (ED) with a spontaneous pneumothorax 
post-SARS-CoV-2 pneumonia, with a pneumatocele discovered on 
radiography. While pneumatoceles are more common within the post-
pneumonia, pediatric population,1 a retrospective study has shown 
pneumatocele development as a missed diagnosis in up to 37% of their 
78 patients with the coronavirus disease.2 Additional studies show 
varying numbers with pneumatocele development seen in 10% of 81 
symptomatic patients in the study by Shi et al.3 and in 5.3% of 57 SARS-
CoV-2 positive patients in the study Qi et al.4 Radiologic studies use 
terms such as ‘cystic air spaces,’2 ‘cystic changes,’3 and ‘emphysema,’4 
which are synonymous with pneumatocele. Pneumatoceles, in relation 
to COVID-19, are highly variable in size; some are categorized as ‘giant 
bullae’5 and typically present in multiples rather than a singular lesion.6 
 
A predictable complication of pneumatoceles is pneumothorax.1,5 A few 
case studies report pneumothoraxes as a rare complication of COVID-
19.7,8 Risk factors for pneumothorax include young age, chest trauma,1 
individuals with imaging demonstrating fibrotic lung changes,9 
individuals with a more severe clinical course, prolonged pneumonitis 
duration, and higher neutrophil counts.10 In our experience with COVID-
19 management, pneumothorax is more common in mechanically 
ventilated patients, which is as high as 13% in one study,11 likely due 
to barotrauma. However, patients are presenting with pneumothoraxes 
well before ventilatory support is provided. 
 
The Case 
A 28-year-old African American male presented to an ED reporting chest 
and back pressure/pain along with shortness of breath. Three weeks 
prior, the patient presented to the same ED in respiratory distress 
secondary to PCR confirmed SARS-CoV-2 pneumonia. He was 
hospitalized for 10 days and received oxygen, remdesivir, 
dexamethasone, tocilizumab, and enoxaparin therapy. The patient did 
not require mechanical ventilation during his prior hospitalization.  
 
 
During the current presentation to the ED for respiratory distress the 
patient was saturating at 82% on room air, which improved to 92% on 
4 liters per minute of nasal cannula oxygen. Chest radiographs revealed 
a large right pneumothorax with subsequent mediastinal shift to the 
left (Figure 1). A pigtail catheter was inserted at the 2nd intercostal 
space along the midclavicular line. 
 
After two days, the catheter accidentally dislodged from the patient’s 
pleural space and serial CXRs were performed to determine whether 
the pneumothorax had resolved. Although the patient was clinically 
asymptomatic, the radiographs showed worsening of the 
pneumothorax; therefore, a pigtail catheter was reinserted at the 4th 
intercostal space along the mid axillary line. The CXR on Day 4 also 
showed formation of a round lesion with central air-fluid levels that 
was speculated to be a pneumatocele (Figure 2). On subsequent 
imaging, the pneumothorax appears to have improved, although not 
completely resolved (Figure 3). The lesion was  monitored  by  a  local  
Highlights: 
 COVID-19 recovery complications are not emphasized in literature as 
much as pathophysiology, clinical treatment, and epidemiology. 
 As the pandemic is taking its course, many patients are recovering 
from COVID-19 but may be at risk for complications. 
 To ensure pneumatoceles are diagnosed and tracked in anticipation 
of spontaneous pneumothorax, we recommend that patients post-
COVID-19 pneumonitis are assessed radiographically before hospital 
discharge and within two weeks after discharge. This will lead to 
early detection of pneumatoceles and will provide an insight into a 
subgroup of COVID-19 patients that may be at risk for multiple 
pathological pulmonary events after COVID-19 hospitalization. This 
will aid physicians in being cognizant regarding this subgroup of 
patients who will benefit from a more stringent monitoring. 
 Larger studies are warranted to distinguish between Long 
COVID/Long-haul COVID/Post-acute sequelae SARS-CoV-2 (PASC) and 
Post-COVID-19 pneumonitis as well as the complications related to 
both these conditions. 
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Figure 1. (A): Patient’s chest x-ray taken during the previous hospitalization, 
showing extensive bilateral interstitial airspace opacities throughout the 
right and left lungs. (B): Patient's chest x-ray at presentation showing a 
large right pneumothorax, with the majority of the right lung collapsed. 
There is mild to moderate mediastinal shift to the left. Both lungs show 




Figure 2. Follow up chest x-ray on Day 4 showing an unresolved right 
pneumothorax (20-30%) and ill-defined pulmonary opacities throughout 
both lungs, deduced to be bilateral interstitial disease. A round lesion with 
central air-fluid levels formed within the right mid lung and was speculated 
to be a pneumatocele 
 
 
pulmonologist and treated daily with fluticasone inhaled therapy, until 
resolution 7 weeks later. 
 
Discussion 
Textbook pneumothorax patients often have a history of a connective 
tissue disorder, such as Marfan syndrome or Ehlers-Danlos syndrome, 
and/or have a characteristic marfanoid habitus, COPD, smoking, or 
pregnancy.12 Our patient denied a recent history of trauma, denied a 
history of smoking, and had a body mass index of 35.9 kg/m2. This 
patient does not fit into the standard demographic of patients at an 
increased risk of pneumothorax and there are still uncertainties 
regarding COVID-19-related lung changes and complications. This led us 
to hypothesize that pneumatoceles may well be a potential mechanism 
behind this pneumothorax.  
 
The percentage of COVID-19 cases that are complicated by 
pneumatocele development has yet to be determined. Pneumatoceles 
typically appear 5-6 days after the infectious process secondary to 
SARS-CoV-2.13 However, spontaneous pneumothorax is a known, rare 
complication of COVID-19 and can occur in the absence of mechanical 
ventilation,14 with studies showing that pneumothorax occurs within a 
window of 14-37 days after hospitalization.7 Pneumothorax is also not 
a common sequel to pneumatoceles as the majority of pneumatoceles 
resolve spontaneously within a few weeks to a year, without 
intervention.1 In this case, while no pneumatocele was identified before 
or at presentation, antecedent rupture of an unacknowledged 
pneumatocele could have led to the pneumothorax. The single 
pneumatocele lesion likely formed due to parenchymal inflammation 
secondary to acute respiratory distress syndrome (ARDS), which is not 
uncommon.15 There have not been any studies that deduce a specific 
mechanism for COVID-19 infection itself eliciting pneumatocele 
formation, without pneumonitis underplay.  
 
Pneumothoraxes are rarely fatal; however, they have recurrence rate of 
up to 32% within 12 months according to one meta-analysis.16 This 
patient’s pneumothorax pathology could have occurred either through 
pneumatocele rupture, which has been reported in other case studies,8 
or due to COVID-19-induced pulmonary parenchymal injury and necrosis 
with development of air leaks into the pleural cavity. While the former 
has not been thoroughly studied due to the relative novelty of COVID-
19, the latter was noted previously during the SARS outbreak.16,17 If 
pulmonary necrosis led to pneumothorax, then the pneumatocele seen 
in this patient was likely an incidental finding.  
 
As per the World Health Organization (WHO), most COVID-19 patients 
experience a mild-to-moderate clinical course, with 10-15% of patients 
progressing to a severe clinical presentation and 5% progressing to 
critical illness. In general, recovery can take anywhere from 2-6 weeks, 
depending on the severity of the case. Unfortunately, some patients 
experience symptoms for weeks to months, regardless of disease 
severity.18 These patients were colloquially deemed ‘long COVID’ or 
‘COVID long-haulers,’ which later became ‘post-acute sequelae of SARS-
CoV-2 (PASC)’. Studies suggest that roughly one-third of those infected 
with SARS-CoV-2, whether asymptomatic during infection or not, may 
develop PASC.19,20 According to a study conducted by Lambert et al.21, 
of the 5,875 COVID-19 survivors surveyed, 5,163 reported symptoms 
persisting longer than 21 days. The most common symptom reported 
was fatigue (79.0%) and followed by headache/migraines (55.3%), 
shortness of breath (55.3%), difficulty concentrating (53.6%), cough 
(49.0%), changed sense of taste (44.9%), diarrhea (43.9%), muscle/body 
aches (43.5%), and heart palpitations (39.5%).21 Another study 
surveying 3,762 respondents from 56 countries reported the most 
frequent symptoms being fatigue (77.7%), post-exertional malaise 
(72.2%), and cognitive dysfunction (55.4%).22 Risk factors for PASC 
include hypertension, obesity, prior mental health conditions,21 and 
female gender (two times increased risk as compared to males). 23 
While COVID-19 is at the forefront of research, a clear distinction must 
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Figure 3. Non-contrast CT scans showing resolution of the pneumothorax. Laterally in right upper lobe, there is oval-shaped lucent lesion measuring 7 cm (AP) 
x 4.6 cm (transverse) x 2.5 cm (cc). Wall is thin and barely perceptible. Inner margin of the cavity is smooth. There is an internal air-fluid level. It is difficult to 
tell if this collection is tracking along the minor fissure. Numerous scattered ground-glass pulmonary opacities are present throughout each lung. 
 
            
 
pneumonitis, as well as their respective complications. Larger 
retrospective cohort studies and case reports, pertaining to both PASC 
and Post-COVID-19 pneumonitis, are warranted. 
 
Conclusion 
Cystic lesions, pneumatoceles, and subsequently pneumothoraxes are 
likely to result from prolonged SARS-CoV-2 pneumonia causing air leaks. 
This is similar to the clinical course observed in patients with SARS, 
caused by a virus within the same Coronaviridae family, during the 
2003 outbreak. To ensure pneumatoceles are diagnosed and tracked in 
anticipation of spontaneous pneumothorax, we recommend that 
patients with post-COVID-19 pneumonitis, especially those given 
ventilator support, are assessed radiographically before hospital 
discharge and within two weeks after discharge. This will lead to early 
detection of pneumatoceles and will provide an insight into a sub-group 
of COVID-19 patients that may be at risk for multiple pathological 
pulmonary events after COVID-19 hospitalization. This could physicians 
in being cognizant regarding this sub-group of patients, who could 
benefit from more stringent monitoring. Furthermore, larger studies are 
warranted to distinguish between Long COVID/Long-haul COVID/Post-
acute sequelae SARS-CoV-2 (PASC) and Post-COVID-19 pneumonitis, as 
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